Metrics to compare | 002198 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002198PeersSector | |
|---|---|---|---|---|
P/E Ratio | 60.3x | 2.9x | −0.4x | |
PEG Ratio | −3.80 | −0.04 | 0.00 | |
Price/Book | 2.3x | 1.8x | 2.6x | |
Price / LTM Sales | 4.3x | 2.9x | 3.1x | |
Upside (Analyst Target) | - | 58.7% | 48.8% | |
Fair Value Upside | Unlock | −3.5% | 5.7% | Unlock |
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Xiaoyan Lidan Tablets, and Jinju Wuhua tea, etc., as well as double throat lozenges and tablets, heavy psychotherapy, Yuqiao detoxification granules, orange peel cough granules, bone-setting Qili tablets and capsules, anti-inflammatory and choleretic tablets, chrysanthemum five-flower tea granules, Zhuang Yao Jian Shen pills, Gujing Shenrong pills, Guifuli Zhongwan, and stomach pain tablets. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.